alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-GlcNAc

Term ID

CHEBI:61832

Synonyms

alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc
beta-D-glucopyranose, O-alpha-D-galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-
Gal-alpha-(1->4)-Gal-beta-(1->4)-GlcNAc-beta
Gal-alpha1-4-Gal-beta1-4-GlcNAc-beta
Gala1-4Galb1-4GlcNAcb
Galalpha(1->4)Galbeta(1->4)GlcNAcbeta
Galalpha1-4Galbeta1-4GlcNAcbeta
O-alpha-D-galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
P1-Tri

Definition

An α-D-Gal-(1→4)-β-D-Gal-(1→4)-D-GlcNAc which has β-configuration at the epimeric hydroxy group.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-GlcNAc

Phenotype where environments contain alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-GlcNAc

Phenotype modified by environments containing alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-GlcNAc

Phenotype affecting alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-GlcNAc

Human Disease Model